FAST · Fastenal Co
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-06-12 | Talwar Vishal |
EVP CDIO & PRESIDENT FDW |
Other↑
|
No Securities Owned
|
0 |
| 2026-06-12 | Talwar Vishal |
EVP CDIO & PRESIDENT FDW |
Other↑
|
No Securities Owned
|
0 |
| 2026-06-12 | Talwar Vishal |
EVP CDIO & PRESIDENT FDW |
Other↑
|
No Securities Owned
|
0 |
| 2026-04-24 | Ancius Michael J |
Director |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option was issued to the reporting person pursuant to the Fastenal Company Non-employee Director Stock Option Plan and in connection with his annual director compensation whereby the option was immediately exercisable. |
Stock Option (Right to Buy)
|
1,000 |
| 2026-04-24 | Ancius Michael J |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
The amount includes 46,668 shares held in a revocable trust over which the reporting person and his wife share voting and investment power and 12,022 shares held in the reporting person's self-directed IRA. |
Common Stock
|
1,000 |
| 2026-03-05 | Wisecup Reyne K |
Director |
Sell↓
|
Common Stock
|
36,920 |
| 2026-03-05 | Wisecup Reyne K |
Director |
Convert↓
Filing footnotes — Employee Stock Option (Right to Buy) (Direct)
The option was previously reported in a filing dated 1/3/2019 as covering 11,538 securities at a strike price of $52 and the amounts were adjusted to reflect a 2-for-1 stock splits on 5/22/2019 and 5/21/2025. The option will fully vest and become exercisable over a period of five years, with 40% vesting and becoming exercisable two years following the date of grant and the remainder vesting and becoming exercisable proportionately (20%) each year thereafter. |
Employee Stock Option (Right to Buy)
|
36,920 |
| 2026-03-05 | Wisecup Reyne K |
Director |
Convert↑
|
Common Stock
|
36,920 |
| 2026-01-23 | SATTERLEE SCOTT |
Director |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option was previously reported in a filing dated January 6, 2020 as covering 12,482 securities at an exercise price of $38.00 and the amounts were adjusted to reflect a 2-for-1 stock split on May 21, 2025. This option was issued to the reporting person pursuant to the Fastenal Company Non-employee Director Stock Option Plan and in connection with his annual director compensation, which option was immediately vested and exercisable on the grant date. |
Stock Option (Right to Buy)
|
15,964 |
| 2026-01-23 | SATTERLEE SCOTT |
Director |
Convert↑
|
Common Stock
|
15,964 |
| 2026-01-23 | SATTERLEE SCOTT |
Director |
Sell↓
|
Common Stock
|
15,964 |
| 2026-01-02 | SATTERLEE SCOTT |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option was issued to the reporting person pursuant to the Fastenal Company Non-employee Director Stock Option Plan and in connection with the reporting person's annual director compensation. |
Stock Option (Right to Buy)
|
17,605 |
| 2026-01-02 | Jansen James C |
EVP-Manufacturing |
Award↑
Filing footnotes — Employee Stock Option (Right to Buy) (Direct)
The option will fully vest and become exercisable over a period of four years, with 25% vesting and becoming exercisable each year following the grant date. |
Employee Stock Option (Right to Buy)
|
17,560 |
| 2026-01-02 | Heise Rita J. |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option was issued to the reporting person pursuant to the Fastenal Company Non-employee Director Stock Option Plan and in connection with the reporting person's annual director compensation. |
Stock Option (Right to Buy)
|
23,474 |
| 2026-01-02 | Tunnicliff Max Hughes |
CFO and Senior EVP |
Award↑
Filing footnotes — Employee Stock Option (Right to Buy) (Direct)
The option will fully vest and become exercisable over a period of six years, with 20% vesting and becoming exercisable each year following the grant date. |
Employee Stock Option (Right to Buy)
|
28,841 |
| 2026-01-02 | Ericson Brady D |
Director, President and CEO |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option was issued to the reporting person pursuant to the Fastenal Company Non-employee Director Stock Option Plan and in connection with the reporting person's annual director compensation. |
Stock Option (Right to Buy)
|
23,474 |
| 2026-01-02 | Broersma Anthony Paul |
EVP-Operations |
Award↑
Filing footnotes — Employee Stock Option (Right to Buy) (Direct)
The option will fully vest and become exercisable over a period of four years, with 25% vesting and becoming exercisable each year following the grant date. |
Employee Stock Option (Right to Buy)
|
17,560 |
| 2026-01-02 | Nielsen Sarah N |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option was issued to the reporting person pursuant to the Fastenal Company Non-employee Director Stock Option Plan and in connection with the reporting person's annual director compensation. |
Stock Option (Right to Buy)
|
14,084 |
| 2026-01-02 | Lisowski Sheryl Ann |
EVP-CAO/Treas. |
Award↑
Filing footnotes — Employee Stock Option (Right to Buy) (Direct)
The option will fully vest and become exercisable over a period of four years, with 25% vesting and becoming exercisable each year following the grant date. |
Employee Stock Option (Right to Buy)
|
17,560 |
| 2026-01-02 | Wisecup Reyne K |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option was issued to the reporting person pursuant to the Fastenal Company Non-employee Director Stock Option Plan and in connection with the reporting person's annual director compensation. |
Stock Option (Right to Buy)
|
11,737 |
| 2026-01-02 | Oas Noelle Joan |
Executive VP-Human Resources |
Award↑
Filing footnotes — Employee Stock Option (Right to Buy) (Direct)
The option will fully vest and become exercisable over a period of four years, with 25% vesting and becoming exercisable each year following the grant date. |
Employee Stock Option (Right to Buy)
|
17,560 |
| 2026-01-02 | Miller Charles S. |
Senior EVP-Sales |
Award↑
Filing footnotes — Employee Stock Option (Right to Buy) (Direct)
The option will fully vest and become exercisable over a period of four years, with 25% vesting and becoming exercisable each year following the grant date. |
Employee Stock Option (Right to Buy)
|
35,670 |
| 2026-01-02 | Papenfuss Donnalee Kathleen |
EVP-Strategy and Communication |
Award↑
Filing footnotes — Employee Stock Option (Right to Buy) (Direct)
The option will fully vest and become exercisable over a period of four years, with 25% vesting and becoming exercisable each year following the grant date. |
Employee Stock Option (Right to Buy)
|
13,719 |
| 2026-01-02 | Drazkowski William Joseph |
EVP-Sales |
Award↑
Filing footnotes — Employee Stock Option (Right to Buy) (Direct)
The option will fully vest and become exercisable over a period of four years, with 25% vesting and becoming exercisable each year following the grant date. |
Employee Stock Option (Right to Buy)
|
31,097 |
| 2026-01-02 | Eastman Stephen L. |
President - PG&A + Aftermarket |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option was issued to the reporting person pursuant to the Fastenal Company Non-employee Director Stock Option Plan and in connection with the reporting person's annual director compensation. |
Stock Option (Right to Buy)
|
11,737 |
| 2026-01-02 | Ancius Michael J |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option was issued to the reporting person pursuant to the Fastenal Company Non-employee Director Stock Option Plan and in connection with the reporting person's annual director compensation. |
Stock Option (Right to Buy)
|
23,474 |
| 2026-01-02 | Soderberg John Lewis |
Senior EVP-IT |
Award↑
Filing footnotes — Employee Stock Option (Right to Buy) (Direct)
The option will fully vest and become exercisable over a period of four years, with 25% vesting and becoming exercisable each year following the grant date. |
Employee Stock Option (Right to Buy)
|
24,390 |
| 2026-01-02 | FLORNESS DANIEL L |
Director |
Award↑
Filing footnotes — Employee Stock Option (Right to Buy) (Direct)
The original report indicated 83,365 derivative securities issued with the Employee Stock Option and the amended report corrects this amount as 85,365 derivative securities. The option will fully vest and become exercisable over a period of four years, with 25% vesting and becoming exercisable each year following the grant date. |
Employee Stock Option (Right to Buy)
|
85,365 |
| 2026-01-02 | Quarshie Irene Ayeley |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option was issued to the reporting person pursuant to the Fastenal Company Non-employee Director Stock Option Plan and in connection with the reporting person's annual director compensation. |
Stock Option (Right to Buy)
|
15,258 |
| 2026-01-02 | Watts Jeffery Michael |
President and Chief Sales Off. |
Award↑
Filing footnotes — Employee Stock Option (Right to Buy) (Direct)
The option will fully vest and become exercisable over a period of four years, with 25% vesting and becoming exercisable each year following the grant date. |
Employee Stock Option (Right to Buy)
|
60,975 |
| 2026-01-02 | HSU Hsenghung Sam |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option was issued to the reporting person pursuant to the Fastenal Company Non-employee Director Stock Option Plan and in connection with the reporting person's annual director compensation. |
Stock Option (Right to Buy)
|
16,431 |
| 2025-12-12 | Ancius Michael J |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
The amount includes 45,668 shares held in a revocable trust over which the reporting person and his wife share voting and investment power and 12,022 shares held in reporting person's self-directed IRA. |
Common Stock
|
1,500 |
| 2025-12-12 | Ancius Michael J |
Director |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option was issued to the reporting person pursuant to the Fastenal Company Non-employee Director Stock Option Plan and in connection with his annual director compensation whereby the option was immediately exercisable. |
Stock Option (Right to Buy)
|
1,500 |
| 2025-11-19 | Nielsen Sarah N |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
On May 21, 2025, the Common Stock of Fastenal Company split 2-for-1 and the amounts reported have been adjusted to reflect the stock split. |
Common Stock
|
1,000 |
| 2025-11-18 | Ancius Michael J |
Director |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option was issued to the reporting person pursuant to the Fastenal Company Non-employee Director Stock Option Plan and in connection with his annual director compensation whereby the option was immediately exercisable. |
Stock Option (Right to Buy)
|
2,000 |
| 2025-11-18 | Ancius Michael J |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
The amount includes 44,168 shares held in a revocable trust over which the reporting person and his wife share voting and investment power and 12,022 shares held in the reporting person's self-directed IRA. |
Common Stock
|
2,000 |
| 2025-11-17 | Johnson Daniel L. |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
On May 21, 2025, the Common Stock of Fastenal Company split 2-for-1 and the amounts reported have been adjusted to reflect the stock split. Shares maintained in a revocable trust, over which the reporting person and his wife share voting and investment power. |
Common Stock
|
1,000 |
| 2025-11-13 | HSU Hsenghung Sam |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
The previous report filed on November 14, 2025 incorrectly stated the price as $49.58. |
Common Stock
|
1,000 |
| 2025-11-12 | Eastman Stephen L. |
President - PG&A + Aftermarket |
Buy↑
Filing footnotes — Common Stock (Direct)
On May 21, 2025, the Common Stock of Fastenal Company split 2-for-1 and the amounts reported have been adjusted to reflect the stock split. Shares maintained in a revocable trust, over which the reporting person shares voting and investment power with his wife. |
Common Stock
|
1,000 |
| 2025-10-16 | HSU Hsenghung Sam |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
On May 21, 2025, the Common Stock of Fastenal Company split 2-for-1 and the amounts reported have been adjusted to reflect the stock split. |
Common Stock
|
1,000 |
| 2025-10-14 | Ancius Michael J |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
On May 22, 2019 and May 21, 2025, the Common Stock of Fastenal Company split 2-for-1 and the amounts reported have been adjusted to reflect the stock split. This amount includes 42,168 shares held in a revocable trust over which the reporting person and his wife share voting and investment power and 12,022 shares held in the reporting person's self-directed IRA. |
Common Stock
|
2,000 |
| 2025-10-14 | Ancius Michael J |
Director |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option was issued to the reporting person pursuant to the Fastenal Company Non-employee Director Stock Option Plan and in connection with his annual director compensation whereby the option is immediately exercisable. On May 22, 2019 and May 21, 2025, the Common Stock of Fastenal Company split 2-for-1 and the amounts reported have been adjusted to reflect the stock split. |
Stock Option (Right to Buy)
|
2,000 |
| 2025-08-15 | Drazkowski William Joseph |
EVP-Sales |
Convert↑
Filing footnotes — Common Stock (Direct)
On May 21, 2025, the Common Stock of Fastenal Company split 2-for-1 and the amounts reported have been adjusted to reflect the stock split. |
Common Stock
|
6,842 |
| 2025-08-15 | Drazkowski William Joseph |
EVP-Sales |
Sell↓
|
Common Stock
|
6,842 |
| 2025-08-15 | Drazkowski William Joseph |
EVP-Sales |
Convert↓
Filing footnotes — Employee Stock Option (Right to Buy) (Direct)
On May 21, 2025, the Common Stock of Fastenal Company split 2-for-1 and the amounts reported have been adjusted to reflect the stock split. The option will fully vest and become exercisable over a period of five years, with 40% vesting and becoming exercisable two years following the date of grant and the remainder vesting and becoming exercisable proportionately (20%) each year thereafter. |
Employee Stock Option (Right to Buy)
|
6,842 |
| 2025-08-12 | FLORNESS DANIEL L |
Director |
Convert↓
Filing footnotes — Employee Stock Option (Right to Buy) (Direct)
On May 22, 2019 and May 21, 2025, the Common Stock of Fastenal Company split 2-for-1 and the amounts reported have been adjusted to reflect these two stock splits. The option will vest and become exercisable over a period of five years, with 40% the option vesting and becoming exercisable two years following the date of grant, and the remainder vesting and becoming exercisable proportionately on each anniversary of the grant date. The report filed on 8/14/2025 incorrectly reported the number of derivative securities beneficially owned following the reported transaction as 0 derivative securities and this report amends the amount. |
Employee Stock Option (Right to Buy)
|
84,612 |
| 2025-08-12 | FLORNESS DANIEL L |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
On May 22, 2019 and May 21, 2025, the Common Stock of Fastenal Company split 2-for-1 and the amounts reported have been adjusted to reflect these two stock splits. |
Common Stock
|
84,612 |
| 2025-08-12 | FLORNESS DANIEL L |
Director |
Sell↓
|
Common Stock
|
84,612 |
| 2025-08-08 | Watts Jeffery Michael |
President and Chief Sales Off. |
Sell↓
|
Common Stock
|
32,724 |
| 2025-08-08 | Watts Jeffery Michael |
President and Chief Sales Off. |
Convert↓
Filing footnotes — Employee Stock Option (Right to Buy) (Direct)
On May 22, 2019 and May 21, 2024, the Common Stock of Fastenal Company spilt 2-for-1 and the amounts reported have been adjusted to reflect these two stock splits. The option will fully vest and become exercisable over a period of five years, with 40% vesting and becoming exercisable two years following the date of grant, and the remainder vesting and becoming exercisable proportionately (20%) each year thereafter. |
Employee Stock Option (Right to Buy)
|
32,724 |